[Creutzfeldt-Jakob spongiform encephalopathy. II. Epidemiologic analysis].

E. Mitrová,M. Drobný,V. Mayer,V. Krajn̆ák

1985-07-01

Abstract:

What problem does this paper attempt to address?

Exploring CJD incidence trends: insights from Slovakia

Pavol Skacik,Egon Kurca,Stefan Sivak

DOI: https://doi.org/10.1080/19336896.2024.2349011

2024-05-10

Prion

Abstract:Authors are commenting on the evolving geographical incidence trends observed with the genetic form of Creutzfeldt-Jakob disease and discussing the diverse array of factors contributing to the heightened incidence rates observed in specific geographical regions.

biochemistry & molecular biology
The importance of ongoing international surveillance for Creutzfeldt–Jakob disease

Neil Watson,Jean-Philippe Brandel,Alison Green,Peter Hermann,Anna Ladogana,Terri Lindsay,Janet Mackenzie,Maurizio Pocchiari,Colin Smith,Inga Zerr,Suvankar Pal

DOI: https://doi.org/10.1038/s41582-021-00488-7

IF: 38.1

2021-05-10

Nature Reviews Neurology

Abstract:Creutzfeldt–Jakob disease (CJD) is a rapidly progressive, fatal and transmissible neurodegenerative disease associated with the accumulation of misfolded prion protein in the CNS. International CJD surveillance programmes have been active since the emergence, in the mid-1990s, of variant CJD (vCJD), a disease linked to bovine spongiform encephalopathy. Control measures have now successfully contained bovine spongiform encephalopathy and the incidence of vCJD has declined, leading to questions about the requirement for ongoing surveillance. However, several lines of evidence have raised concerns that further cases of vCJD could emerge as a result of prolonged incubation and/or secondary transmission. Emerging evidence from peripheral tissue distribution studies employing high-sensitivity assays suggests that all forms of human prion disease carry a theoretical risk of iatrogenic transmission. Finally, emerging diseases, such as chronic wasting disease and camel prion disease, pose further risks to public health. In this Review, we provide an up-to-date overview of the transmission of prion diseases in human populations and argue that CJD surveillance remains vital both from a public health perspective and to support essential research into disease pathophysiology, enhanced diagnostic tests and much-needed treatments.

clinical neurology
Surveillance for Creutzfeldt-Jakob Disease in China from 2006 to 2007

Qi Shi,Chen Gao,Wei Zhou,Bao-Yun Zhang,Jian-Ming Chen,Chan Tian,Hui-Ying Jiang,Jun Han,Ni-Juan Xiang,Xiao-Fang Wang,Yong-Jun Gao,Xiao-Ping Dong

DOI: https://doi.org/10.1186/1471-2458-8-360

IF: 4.5

2008-01-01

BMC Public Health

Abstract:Background: Human transmissible spongiform encephalopathies (HTSE), or Creutzfeldt-Jakob disease (CJD), is a group of rare and fatal diseases in central nervous system. Since outbreak of bovine spongiform encephalopathy (BSE) and variant CJD, a worldwide CJD surveillance network has been established under the proposition of WHO. In China, a national CJD surveillance system has started since 2002. The data of CJD surveillance from 2006 to 2007 was analyzed.Methods: Total 12 provinces are included in CJD surveillance system. The surveillance unit in each province consists of one or two sentinel hospitals and the provincial CDC. All suspected CJD cases reported from CJD surveillance were diagnosed and subtyped based on the diagnostic criteria for CJD issued by WHO.Results: Total 192 suspected CJD cases were reported and 5 genetic CJD, 51 probable and 30 possible sporadic CJD (sCJD) cases were diagnosed. The collected sCJD cases distribute sporadically without geographical clustering and seasonal relativity and the highest incidences in both probable and possible sCJD cases appeared in the group of 60-69 year. The most common three foremost symptoms were progressive dementia, cerebellum and mental-related symptoms. The probable sCJD patients owning both typical EEG alteration and CSF protein 14-3-3 positive have more characteristic clinical syndromes than the ones having only one positive. The polymorphisms of codon 129 of all tested reported cases shows typical patterns of Han Chinese as previous reports, that M129M are predominant whereas M129V are seldom.Conclusion: Chinese CJD patients possessed similar epidemiological and clinical characteristics as worldwide.
Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications

Clare R Trevitt,Pramil N Singh

DOI: https://doi.org/10.1093/ajcn/78.3.651S

Abstract:Prion diseases, or transmissible spongiform encephalopathies, include Creutzfeldt-Jakob disease (CJD) in humans and scrapie and bovine spongiform encephalopathy (BSE) in animals. These neurodegenerative diseases are invariably fatal and can be transmitted by inoculation or dietary exposure. They are associated with the accumulation of an altered, disease-associated form of the normal prion protein. Pathologically, prion diseases result in neuronal cell death and a characteristic spongiform appearance of the brain tissue. The emergence of a variant form of CJD (vCJD) in the United Kingdom in 1996 has been causally and experimentally linked to the UK BSE epidemic in the 1980s and early 1990s. The finding that BSE is transmissible to different animal species, unlike previously characterized prion diseases such as sheep scrapie, has raised enormous public health concerns worldwide. Although it is not yet possible to gauge the size of a potential vCJD epidemic, preliminary data indicate a significant dietary exposure to BSE-infected material in Britain and wider implications of the transmissibility of prion diseases. The threat to public health has intensified research efforts to understand the molecular basis of prion diseases, understand their transmission between species, improve methods of diagnosis, and develop therapeutic strategies for treatment and prevention of disease. In this review, we summarize current data on the pathology of BSE and vCJD and the epidemiology of vCJD, and we outline public health implications based on these data, emphasizing preventative measures and areas of research for screening and diagnosis.
A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts

Maria Carolina Jurcau,Anamaria Jurcau,Razvan Gabriel Diaconu,Vlad Octavian Hogea,Vharoon Sharma Nunkoo

DOI: https://doi.org/10.3390/neurolint16050079

2024-09-20

Abstract:Creutzfeldt-Jakob disease is a rare neurodegenerative and invariably fatal disease with a fulminant course once the first clinical symptoms emerge. Its incidence appears to be rising, although the increasing figures may be related to the improved diagnostic tools. Due to the highly variable clinical picture at onset, many specialty physicians should be aware of this disease and refer the patient to a neurologist for complete evaluation. The diagnostic criteria have been changed based on the considerable progress made in research on the pathogenesis and on the identification of reliable biomarkers. Moreover, accumulated knowledge on pathogenesis led to the identification of a series of possible therapeutic targets, although, given the low incidence and very rapid course, the evaluation of safety and efficacy of these therapeutic strategies is challenging.
Biomarkers Analysis and Clinical Manifestations in Comorbid Creutzfeldt–Jakob Disease: A Retrospective Study in 215 Autopsy Cases

Nikol Jankovska,Robert Rusina,Jiri Keller,Jaromir Kukal,Magdalena Bruzova,Eva Parobkova,Tomas Olejar,Radoslav Matej

DOI: https://doi.org/10.3390/biomedicines10030680

IF: 4.757

2022-03-16

Biomedicines

Abstract:Creutzfeldt–Jakob disease (CJD), the most common human prion disorder, may occur as “pure” neurodegeneration with isolated prion deposits in the brain tissue; however, comorbid cases with different concomitant neurodegenerative diseases have been reported. This retrospective study examined correlations of clinical, neuropathological, molecular-genetic, immunological, and neuroimaging biomarkers in pure and comorbid CJD. A total of 215 patients have been diagnosed with CJD during the last ten years by the Czech National Center for Prion Disorder Surveillance. Data were collected from all patients with respect to diagnostic criteria for probable CJD, including clinical description, EEG, MRI, and CSF findings. A detailed neuropathological analysis uncovered that only 11.16% were “pure” CJD, while 62.79% had comorbid tauopathy, 20.47% had Alzheimer’s disease, 3.26% had frontotemporal lobar degeneration, and 2.33% had synucleinopathy. The comorbid subgroup analysis revealed that tauopathy was linked to putaminal hyperintensity on MRIs, and AD mainly impacted the age of onset, hippocampal atrophy on MRIs, and beta-amyloid levels in the CSF. The retrospective data analysis found a surprisingly high proportion of comorbid neuropathologies; only 11% of cases were verified as “pure” CJD, i.e., lacking hallmarks of other neurodegenerations. Comorbid neuropathologies can impact disease manifestation and can complicate the clinical diagnosis of CJD.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins

P Horby

DOI: https://doi.org/10.1046/j.1440-1754.2002.00055.x

Abstract:Variant Creutzfeldt-Jakob disease (vCJD) is an emerging infectious disease believed to be the human manifestation of bovine spongiform encephalopathy (BSE). Variant CJD belongs to a family of human and animal diseases called transmissible spongiform encephalopathies (TSE). The pathogenesis of TSE is not fully understood, but a modified form of a normal cellular protein plays a central role. Current measures to control vCJD aim to prevent transmission of the infectious agent from animals to humans through food or pharmaceutical products and to prevent transmission from person to person via medical interventions. The anticipated development of preclinical diagnostic tests and treatments for vCJD will create new control options and difficult choices.
Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain

Azra C. Ghani,Neil M. Ferguson,Christl A. Donnelly,Thomas J. Hagenaars,Roy M. Anderson

DOI: https://doi.org/10.1098/rspb.1998.0596

1998-12-22

Proceedings of the Royal Society of London. Series B: Biological Sciences

Abstract:Understanding the epidemiology and aetiology of new-variant Creutzfeldt-Jakob (vCJD) disease in humans has become increasingly important given the scientific evidence linking it to bovine spongiform encephalopathy (BSE) in cattle and hence the wide exposure of the population of Great Britain (GB) to potentially infectious tissue. The recent analysis undertaken to determine the risk to the population from dorsal route ganglia illustrated the danger in presenting point estimates rather than ranges of scenarios in the face of uncertainty. We present a mathematical template that relates the past pattern of the BSE epidemic in cattle to the future course of any vCJD epidemic in humans, and use extensive scenario analysis to explore the wide range of possible outcomes given the uncertainty in epidemiological determinants. We demonstrate that the average number of humans infected by one infectious bovine and the incubation period distribution are the two epidemiological factors that have the greatest impact on epidemic size and duration. Using the time-series of the BSE epidemic and the cases seen to date, we show that the minimum length of the incubation period is approximately nine years, and that at least 20% of the cases diagnosed to date were exposed prior to 1986. We also demonstrate that the current age distribution of vCJD cases can only arise if younger people were either exposed to a greater extent, more susceptible to infection, or have shorter incubation periods. Extensive scenario analyses show that given the information currently available, the very high degree of uncertainty in the future size of the epidemic will remain for the next 3-5 years. Furthermore, we demonstrate that this uncertainty is unlikely to be reduced by mass screening for late-stage infection.
Neurotization improves contractile forces of tissue-engineered skeletal muscle.

V. Dhawan,Ian F. Lytle,D. Dow,Yen-Chih Huang,David L. Brown

DOI: https://doi.org/10.1089/TEN.2007.0003

2007-11-01

Tissue Engineering

Abstract:Engineered functional skeletal muscle would be beneficial in reconstructive surgery. Our previous work successfully generated 3-dimensional vascularized skeletal muscle in vivo. Because neural signals direct muscle maturation, we hypothesized that neurotization of these constructs would increase their contractile force. Additionally, should neuromuscular junctions (NMJs) develop, indirect stimulation (via the nerve) would be possible, allowing for directed control. Rat myoblasts were cultured, suspended in fibrin gel, and implanted within silicone chambers around the femoral vessels and transected femoral nerve of syngeneic rats for 4 weeks. Neurotized constructs generated contractile forces 5 times as high as the non-neurotized controls. Indirect stimulation via the nerve elicited contractions of neurotized constructs. Curare administration ceased contraction in these constructs, providing physiologic evidence of NMJ formation. Histology demonstrated intact muscle fibers, and immunostaining positively identified NMJs. These results indicate that neurotization of engineered skeletal muscle significantly increases force generation and causes NMJs to develop, allowing indirect muscle stimulation.
[Study on the Characteristic of Surveillance Creutzfeldt-Jakob Disease Patients from January to August in 2006 in China].

Chen Gao,Jun Han,Wei Zhou,Jian-Ming Chen,Qi Shi,Bao-Yun Zhang,Ni-Juan Xiang,Yong-Jun Gao,Xiao-Ping Dong

DOI: https://doi.org/10.3760/cma.j.issn.1003-9279.2007.03.004

2007-01-01

Abstract:OBJECTIVE:To describe the incidence condition and characteristic of Creutzfeldt-Jakob disease (CJD) in China.METHODS:The clinical and epidemical information of patients from China CJD surveillance network was analyzed. Blood and cerebrospinal fluid (CSF) specimens from these patients were differently collected to be used to detect the 14-3-3 protein in the CSF and to analyze the PRNP gene.RESULTS:Ten possible and 8 probable clinically diagnosed CJD patients were found. These patients had sporadic CJD. There were no geographic clustering and occupational risk with these patients. The mean age at onset of disease was approximately 60 years. The male to female ratio was approximately 1:1; rapidly progressive dementia was the main early symptom, which was present in 44% of patients.CONCLUSION:The geographic distribution, occupation, the ratio of male to female and the mean age of onset were consistent with the characteristics of sporadic CJD.
[Study on the Characteristics of Patients with Creutzfeldt-Jakob Disease under 2008 Surveillance Data in China].

Chan Tian,Chen Gao,Qi Shi,Jun Han,Wei Zhou,Bao-Yun Zhang,Yong-Jun Gao,Xiao-Ping Dong

DOI: https://doi.org/10.3760/cma.j.issn.0254-6450.2009.07.017

2009-01-01

Abstract:OBJECTIVE:To describe the epidemiological and clinical characteristics of Creutzfeldt-Jakob disease (CJD) in China.METHODS:Clinical and epidemical data on patients from China CJD surveillance network was analyzed. Blood and cerebral spinal fluid (CSF) specimens from these patients were collected. Western blot assay was used to detect 14-3-3 protein in CSF, PCR and sequencing assay were used for analyzing the polymorphism of 129 amino acid and mutation of PRNP gene.RESULTS:A total number of 31 probable and 11 possible sporadic CJD patients were identified. Additionally,one patient with Gerstmann-Straussler-Scheinker syndrome (GSS) and 2 familial CJD cases were identified. No geographic- or occupational-related events were observed among these cases. The mean age of onset on the probable or possible CJD patients were 56.7 and 57.4 years old, with sex ratios of the probable CJD patients as 8:9 and the possible one as 5:6 respectively. Rapid progressive dementia was the main foremost symptom, presenting in 33.3% of the CJD patients. Probable CJD patients showed more clinical manifestations than those possible ones.CONCLUSION:Geography distribution, occupation, ratio of gender and the mean onset age of the CJD cases in 2008 were consistent with the characteristics of the sporadic CJD.
Different Expression Patterns of Ck2 Subunits in the Brains of Experimental Animals and Patients with Transmissible Spongiform Encephalopathies

Jian-Ming Chen,Chen Gao,Qi Shi,Bing Shan,Yan-Jun Lei,Chen-Fang Dong,Run An,Gui-Rong Wang,Bao-Yun Zhang,Jun Han,Xiao-Ping Dong

DOI: https://doi.org/10.1007/s00705-008-0084-z

IF: 2.685

2008-01-01

Archives of Virology

Abstract:To address the possible alteration of casein kinase 2 (CK2) in transmissible spongiform encephalopathies (TSEs), the levels and patterns of CK2 in the brain tissues of hamsters or C57BL mice inoculated intracerebrally with scrapie agents 263K or 139A were evaluated by Western blots, followed by quantitative analysis. Specific semi-quantitative RT-PCR for evaluating the mRNA transcripts of CK2 subunits was performed in parallel. Compared with normal animals, the levels of CK2α and CK2β in the brains of infected hamsters and mice were significantly decreased, regardless of which scrapie agent was. However, the expression of CK2α′ or CK2α′/CK2α′′ in the animals infected with agents 263K or 139A was considerably increased. Furthermore, decreases of CK2α and CK2β and increases of CK2α′/CK2α′′ were observed in cerebella homogenates from one familial Creutzfeldt-Jakob disease (fCJD) case and one fatal familial insomnia (FFI) case. These results suggest that alterations of CK2 subunits in brains are illness-correlative phenomena in TSEs and indicate a potential linkage of CK2 changes with the pathogenesis of prion diseases.
High Incidence of Sporadic Creutzfeldt-Jakob Disease in Slovenia in 2015: A Case Series

Tomaž Rus,Bogdan Lorber,Maja Trošt,Srečko Dobrecovič,Nuška Čakš Jager,Mara Popović,Milica G. Kramberger,Nuška Čakš Jager,Milica G. Kramberger

DOI: https://doi.org/10.1159/000486712

2018-02-08

Dementia and Geriatric Cognitive Disorders Extra

Abstract:Background: Creutzfeldt-Jakob disease (CJD) is a rare fatal neurodegenerative disorder presenting with rapid cognitive decline and additional signs. The clinical characteristics of an increasing number of sporadic CJD (sCJD) patients admitted to the Ljubljana University Medical Centre are presented as well as the incidence of sCJD in Slovenia in 2015 compared to previous years. Methods: We investigated patients presenting with rapidly progressive dementia and at least one additional sign. The diagnosis was made based on clinical diagnostic criteria and an autopsy was performed in all cases. Data on definite sCJD cases in Slovenia since 1999 were obtained and its incidence was calculated. Results: Eight patients with definite sCJD died in 2015 in Slovenia (incidence: 3.89 cases per million). The long-term incidence 1999 was 1.67 per million. Conclusions: The incidence of sCJD was considerably higher in 2015. It reflects fluctuations in sporadic cases of this rare disease. The rising trend might indicate a previous underestimation and better recognition of the disease.
The Epidemiological, Clinical, and Laboratory Features of Sporadic Creutzfeldt-Jakob Disease Patients in China: Surveillance Data from 2006 to 2010.

Chen Gao,Qi Shi,Chan Tian,Cao Chen,Jun Han,Wei Zhou,Bao-Yun Zhang,Hui-Ying Jiang,Jin Zhang,Xiao-Ping Dong

DOI: https://doi.org/10.1371/journal.pone.0024231

IF: 3.7

2011-01-01

PLoS ONE

Abstract:BACKGROUND: Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive fatal central nervous system disorder, which consists of three main catalogues: sporadic, familial, and iatrogenic CJD. METHODOLOGY/PRINCIPAL FINDINGS: In China, the surveillance for CJD started in 2006, covering 12 provincial Centers for Disease Control and Prevention (CDCs) and 15 hospitals. From 2006 to 2010, 624 suspected patients were referred to China CJD surveillance. The epidemiological, clinical and laboratory features of sporadic CJD (sCJD) were analysed. Both groups of probable and possible sCJD showed highest incidences in the population of 60 to 69 year-olds. The most common presenting symptoms were progressive dementia and mental-related symptoms (neurological symptoms including sleeping turbulence, depression, anxiety and stress). Among the four main clinical manifestations, myoclonus was more frequently observed in the probable sCJD patients. About 2/3 of probable sCJD cases showed positive 14-3-3 in CSF and/or periodic sharp wave complexes (PSWC) in electroencephalography (EEG). The presence of myoclonus was significantly closely related with the appearance of PSWC in EEG. Polymorphisms of codon 129 in PRNP of the notified cases revealed a highly predominant M129M genotype in Han Chinese. Among 23 genetic human prion diseases, ten were D178N/M129M Fatal familial insomnia (FFI) and five were T188K genetic CJD (gCJD), possibly indicating a special distribution of gCJD-related mutations in Han Chinese. CONCLUSION: From the period of 2006 to 2010, 261 patients were diagnosed as sCJD and 23 patients were diagnosed as genetic human prion diseases in China. The epidemiological, clinical and laboratory analysis data were consistent with the characteristics of sporadic CJD, which provide insight into the features of CJD in China.
EEG – Imaging Evolution of the MV2 Subtype of Sporadic Creutzfeldt-Jakob Disease During the two-Year Course of the Disease

Afrantou Theodora,Syntila Styliani-Aggeliki,Ioannidis Panagiotis,Sklaviadis Theodoros,Boziki Marina,Grigoriadis Nikolaos

DOI: https://doi.org/10.1177/15500594221101628

IF: 2.046

2022-05-19

Clinical EEG and Neuroscience

Abstract:Clinical EEG and Neuroscience, Ahead of Print. Sporadic Creutzfeldt–Jakob disease (sCJD) is a rare transmissible disease. According to molecular classification, six clinical phenotypes of sCJD have been described: MM1, MM2, MV1, MV2, VV1 and VV2. MV2 subtype comprises 9% of sCJD cases. Atypical clinical course has been reported to be the main caveat for the diagnosis of the MV2 subtype. We hereby present a rare case of MV2 subtype of sCJD, highlighting the evolution of clinical, EEG and imaging attributes over a two-year period, thus underlining the atypical course of the disease.

psychology,clinical neurology,psychiatry,neurosciences,neuroimaging
Study on the Characteristics of the Surveiled Creutzfeldt-Jakob Disease Patients in 2009 in China

SHI Qi,GAO Chen,CHEN Cao,ZHOU Wei,ZHANG Bao-yun,TIAN Chan,HAN Jun,DONG Xiao-ping

DOI: https://doi.org/10.3784/j.issn.1003-9961.2010.10.003

2010-01-01

Abstract:Objective To describe epidemiological and clinical characteristics of Creutzfeldt-Jakob disease(CJD)patients in China.Methods The clinical and epidemical information of patients from China CJD surveillance network was analyzed.Blood and cerebral spinal fluid(CSF) specimens from these patients were collected.Western blot assay was used for detecting PrPSc in brain tissue and 14-3-3 protein in CSF,PCR and sequencing assay were used for was used for detecting PrPSc in brain tissue and 14-3-3 protein in CSF,PCR and sequencing assay were used for analyzing the polymorphism of 129 amino acid and mutation of PRNP gene.Results Totally 1 definite CJD patient,31 probable and 31 possible sporadic CJD patients were identified.Additionally,3 FFI cases and 3 genetic CJD cases including G114V,E196K,T188K were definitely diagnosed.No period-,geographic-or occupational-related events were observed among these cases.The mean onset age of probably and possibly diagnosed CJD patients were 60 and 52 years old,respectively.The male to female ratio of the probable CJD patients was 12∶ 19 while that of the possible CJD patients was 14∶ 17.Rapidly progressive dementia was the main foremost symptom,presenting in 48.4% of the CJD patients.Probable CJD patients showed more clinical manifestations than that of the possible one.Conclusion The period and geography distribution,occupation,the ratio of gender and the mean onset age of the CJD cases in 2009 were consistent with the general characteristics of sporadic CJD in the world.
Comprehensive clinical, radiological, pathological and biochemical analysis required to differentiate VV1 sporadic Creutzfeldt-Jakob disease from suspected variant CJD

Sarah Holper,Victoria Lewis,Robb Wesselingh,Frank Gaillard,Steven J Collins,Helmut Butzkueven

DOI: https://doi.org/10.1136/bmjno-2022-000299

2022-04-01

BMJ Neurology Open

Abstract:Background A diagnosis of variant Creutzfeldt-Jakob disease (vCJD), the zoonotic prion disease related to transmission of bovine spongiform encephalopathy, can carry enormous public health ramifications. Until recently, all vCJD clinical cases were confined to patients displaying methionine homozygosity (MM) at codon 129 of the prion protein gene ( PRNP ). The recent diagnosis of vCJD in a patient heterozygous (MV) at codon 129 reignited concerns regarding a second wave of vCJD cases, with the possibility of phenotypic divergence from MM vCJD and greater overlap with sporadic CJD (sCJD) molecular subtypes. Method and results We present a case of CJD with clinico-epidemiological and radiological characteristics creating initial concerns for vCJD. Thorough case evaluation, including data provided by genetic testing, autopsy and neuropathological histological analyses, provided a definitive diagnosis of the rare VV1 molecular subtype of sCJD. Conclusion Distinguishing vCJD from sCJD is of vital public health importance and potentially more problematic with the development of non-MM vCJD cases. The patient described herein demonstrates that in addition to the clinico-epidemiological profile, combined supplementary pathological, biochemical and critical radiological analysis may be necessary for confident discrimination of sCJD, especially rare sub-types, from vCJD.
Neue Variante der Creutzfeldt-Jakob-Krankheit (vCJK)

Stefan Goebel,Peter Hermann,Inga Zerr

DOI: https://doi.org/10.1055/a-2287-7576

2024-05-24

DMW - Deutsche Medizinische Wochenschrift

Abstract:Bei der neuen Variante der Creutzfeldt-Jakob-Krankheit (vCJK) handelt es sich um eine humane Prionerkrankung, bei der Ablagerungen sogenannter pathologisch gefalteter Prionproteine im zentralen Nervensystem zu einem Untergang von Neuronen führen. Dies hat eine Vielzahl neurologischer Symptome zur Folge. Ursächlich wird die vCJK dabei mit der bovinen spongiformen Enzephalopathie (BSE) der Rinder in Verbindung gebracht. Article published online: 23 May 2024 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

medicine, general & internal
Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances

Maria Caramelli,Giuseppe Ru,Pierluigi Acutis,Gianluigi Forloni

DOI: https://doi.org/10.2165/00023210-200620010-00002

CNS Drugs

Abstract:The bovine spongiform encephalopathy (BSE) epidemic, along with the related threat to human health posed by the transmission of the BSE agent to humans, has highlighted the importance of prion diseases. These fatal neurodegenerative diseases are characterised by spongiform changes in the CNS, and comprise a wide spectrum of clinicopathological entities in humans and animals, such as Creutzfeldt-Jakob disease (CJD) and its emerging new variant (vCJD) in humans, and BSE and scrapie in animals. This article reviews the geographical distribution and the temporal trends of CJD and vCJD; the major events in the pathogenesis of prion diseases; the risk factors for sporadic CJD and vCJD; and the possible strategies for treating them. Worldwide statistics indicate that sporadic CJD has a stable incidence of one case per million people per year; in contrast, the incidence of vCJD appears to have increased exponentially from its characterisation in 1994 to a peak in 2000. As of December 2005, 183 definite or probable cases of vCJD had been reported worldwide. The crucial event in the pathogenesis of prion diseases is the conversion of the normally occurring cellular prion protein (PrP(c)) into a pathogenic form, called protease-resistant PrP (PrP(res)) or scrapie PrP (PrP(sc)). Pathogenetic studies in rodent models have shown that PrP(sc) is found in the enteric nervous system and in the gut-associated lymphoid tissue following oral scrapie ingestion. The role of the lymphoreticular system in the pathogenesis of TSE seems to be related to the strains of agents and the host genotype. Therapeutic approaches to vCJD are mainly based on the inhibition or prevention of the pathological change that creates PrP(sc). Derivatives of acridine (such as mepacrine [quinacrine]) and the phenothiazine psychotropics have been proposed as possible therapies because of their activity in cellular models; however, neither class was able to affect the protease resistance of preexisting PrP fibrils. More encouragingly, in animal models of prion disease, tetracyclines were found to reduce prion infectivity by direct inactivation of PrP(sc). While these findings are promising, the suitability of these compounds for clinical use is still limited by their low efficacy once symptoms are apparent. Treatments based on the vaccination approach have also produced positive results, but further investigations are necessary to establish their clinical application.
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

Ellen Gelpi,Simone Baiardi,Carlos Nos,Sofia Dellavalle,Iban Aldecoa,Raquel Ruiz-Garcia,Lourdes Ispierto,Domingo Escudero,Virgina Casado,Elena Barranco,Anuncia Boltes,Laura Molina-Porcel,Nuria Bargalló,Marcello Rossi,Angela Mammana,Dorina Tiple,Luana Vaianella,Elisabeth Stoegmann,Ingrid Simonitsch-Klupp,Gregor Kasprian,Sigrid Klotz,Romana Höftberger,Herbert Budka,Gabor G. Kovacs,Isidre Ferrer,Sabina Capellari,Raquel Sanchez-Valle,Piero Parchi

DOI: https://doi.org/10.1186/s40478-022-01415-7

2022-08-18

Acta Neuropathologica Communications

Abstract:The methionine (M)—valine (V) polymorphic codon 129 of the prion protein gene ( PRNP ) plays a central role in both susceptibility and phenotypic expression of sporadic Creutzfeldt-Jakob diseases (sCJD). Experimental transmissions of sCJD in humanized transgenic mice led to the isolation of five prion strains, named M1, M2C, M2T, V2, and V1, based on two major conformations of the pathological prion protein (PrP Sc , type 1 and type 2), and the codon 129 genotype determining susceptibility and propagation efficiency. While the most frequent sCJD strains have been described in codon 129 homozygosis (MM1, MM2C, VV2) and heterozygosis (MV1, MV2K, and MV2C), the V1 strain has only been found in patients carrying VV. We identified six sCJD cases, 4 in Catalonia and 2 in Italy, carrying MV at PRNP codon 129 in combination with PrP Sc type 1 and a new clinical and neuropathological profile reminiscent of the VV1 sCJD subtype rather than typical MM1/MV1. All patients had a relatively long duration (mean of 20.5 vs. 3.5 months of MM1/MV1 patients) and lacked electroencephalographic periodic sharp-wave complexes at diagnosis. Distinctive histopathological features included the spongiform change with vacuoles of larger size than those seen in sCJD MM1/MV1, the lesion profile with prominent cortical and striatal involvement, and the pattern of PrP Sc deposition characterized by a dissociation between florid spongiform change and mild synaptic deposits associated with coarse, patch-like deposits in the cerebellar molecular layer. Western blot analysis of brain homogenates revealed a PrP Sc type 1 profile with physicochemical properties reminiscent of the type 1 protein linked to the VV1 sCJD subtype. In summary, we have identified a new subtype of sCJD with distinctive clinicopathological features significantly overlapping with those of the VV1 subtype, possibly representing the missing evidence of V1 sCJD strain propagation in the 129MV host genotype.

neurosciences

[Creutzfeldt-Jakob spongiform encephalopathy. II. Epidemiologic analysis].

Exploring CJD incidence trends: insights from Slovakia

The importance of ongoing international surveillance for Creutzfeldt–Jakob disease

Surveillance for Creutzfeldt-Jakob Disease in China from 2006 to 2007

Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications

A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts

Biomarkers Analysis and Clinical Manifestations in Comorbid Creutzfeldt–Jakob Disease: A Retrospective Study in 215 Autopsy Cases

Variant Creutzfeldt-Jakob disease: an unfolding epidemic of misfolded proteins

Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain

Neurotization improves contractile forces of tissue-engineered skeletal muscle.

[Study on the Characteristic of Surveillance Creutzfeldt-Jakob Disease Patients from January to August in 2006 in China].

[Study on the Characteristics of Patients with Creutzfeldt-Jakob Disease under 2008 Surveillance Data in China].

Different Expression Patterns of Ck2 Subunits in the Brains of Experimental Animals and Patients with Transmissible Spongiform Encephalopathies

High Incidence of Sporadic Creutzfeldt-Jakob Disease in Slovenia in 2015: A Case Series

The Epidemiological, Clinical, and Laboratory Features of Sporadic Creutzfeldt-Jakob Disease Patients in China: Surveillance Data from 2006 to 2010.

EEG – Imaging Evolution of the MV2 Subtype of Sporadic Creutzfeldt-Jakob Disease During the two-Year Course of the Disease

Study on the Characteristics of the Surveiled Creutzfeldt-Jakob Disease Patients in 2009 in China

Comprehensive clinical, radiological, pathological and biochemical analysis required to differentiate VV1 sporadic Creutzfeldt-Jakob disease from suspected variant CJD

Neue Variante der Creutzfeldt-Jakob-Krankheit (vCJK)

Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances

Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease